Breaking News Instant updates and real-time market news.

EMN

Eastman Chemical

$114.12 /

-2.8 (-2.39%)

08:41
06/21/21
06/21
08:41
06/21/21
08:41

Eastman Chemical upgraded to Outperform at Scotiabank

As previously reported, Scotiabank analyst Ben Isaacson upgraded Eastman Chemical to Outperform from Sector Perform with a price target of $145, up from $104. Eastman should continue to re-rate as it sheds weaker businesses, said Isaacson, who sees the company having "ample balance sheet firepower" to keep upgrading its portfolio. He "conservatively" projects about 8% EPS growth annually for Eastman, which he notes is at the high end of its peer group.

EMN Eastman Chemical
$114.12 /

-2.8 (-2.39%)

06/21/21 Scotiabank
Eastman Chemical upgraded to Outperform from Sector Perform at Scotiabank
06/14/21 Deutsche Bank
Eastman Chemical price target raised to $140 from $132 at Deutsche Bank
06/09/21 Wolfe Research
Eastman Chemical initiated with an Outperform at Wolfe Research
05/11/21 Goldman Sachs
Eastman Chemical upgraded to Buy from Neutral at Goldman Sachs

TODAY'S FREE FLY STORIES

Earnings
Opiant Pharmaceuticals reports Q2 EPS 31c, consensus (28c) » 16:15
08/05/21
08/05
16:15
08/05/21
16:15
OPNT

Opiant Pharmaceuticals

$15.67 /

+0.28 (+1.82%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPNT Opiant Pharmaceuticals
$15.67 /

+0.28 (+1.82%)

OPNT Opiant Pharmaceuticals
$15.67 /

+0.28 (+1.82%)

07/07/21 Northland
Opiant's positive topline results a 'major de-risking event,' says Northland
OPNT Opiant Pharmaceuticals
$15.67 /

+0.28 (+1.82%)

OPNT Opiant Pharmaceuticals
$15.67 /

+0.28 (+1.82%)

Earnings
Allscripts backs FY21 revenue view $1.5B, consensus $1.5B » 16:15
08/05/21
08/05
16:15
08/05/21
16:15
MDRX

Allscripts

$17.15 /

+0.07 (+0.41%)

Raises FY21 adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDRX Allscripts
$17.15 /

+0.07 (+0.41%)

MDRX Allscripts
$17.15 /

+0.07 (+0.41%)

05/20/21 Deutsche Bank
Allscripts price target raised to $17 from $15 at Deutsche Bank
04/29/21 JPMorgan
Allscripts resumed with an Underweight at JPMorgan
03/02/21 Argus
Allscripts downgraded to Hold from Buy at Argus
03/02/21 Argus
Allscripts downgraded to Hold from Buy at Argus
MDRX Allscripts
$17.15 /

+0.07 (+0.41%)

Upgrade
Global Payments upgraded to Outperform from Market Perform at BMO Capital » 16:15
08/05/21
08/05
16:15
08/05/21
16:15
GPN

Global Payments

$170.31 /

+4.905 (+2.97%)

BMO Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GPN Global Payments
$170.31 /

+4.905 (+2.97%)

GPN Global Payments
$170.31 /

+4.905 (+2.97%)

08/04/21 Barclays
Global Payments price target lowered to $220 from $235 at Barclays
08/03/21 Raymond James
Global Payments price target lowered to $220 from $240 at Raymond James
08/03/21 Rosenblatt
Global Payments selloff due to Afterpay acquisition, says Rosenblatt
08/03/21 Citi
Global Payments post-earnings selloff 'perplexing,' says Citi
GPN Global Payments
$170.31 /

+4.905 (+2.97%)

GPN Global Payments
$170.31 /

+4.905 (+2.97%)

GPN Global Payments
$170.31 /

+4.905 (+2.97%)

Earnings
Allscripts reports Q2 adjusted EPS 23c, consensus 17c » 16:15
08/05/21
08/05
16:15
08/05/21
16:15
MDRX

Allscripts

$17.15 /

+0.07 (+0.41%)

Reports Q2 revenue $374M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDRX Allscripts
$17.15 /

+0.07 (+0.41%)

MDRX Allscripts
$17.15 /

+0.07 (+0.41%)

05/20/21 Deutsche Bank
Allscripts price target raised to $17 from $15 at Deutsche Bank
04/29/21 JPMorgan
Allscripts resumed with an Underweight at JPMorgan
03/02/21 Argus
Allscripts downgraded to Hold from Buy at Argus
03/02/21 Argus
Allscripts downgraded to Hold from Buy at Argus
MDRX Allscripts
$17.15 /

+0.07 (+0.41%)

Earnings
Collegium Pharmaceutical reports Q2 EPS $1.79, consensus 36c » 16:15
08/05/21
08/05
16:15
08/05/21
16:15
COLL

Collegium Pharmaceutical

$24.83 /

-0.1 (-0.40%)

Net income included…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COLL Collegium Pharmaceutical
$24.83 /

-0.1 (-0.40%)

COLL Collegium Pharmaceutical
$24.83 /

-0.1 (-0.40%)

01/11/21 H.C. Wainwright
Collegium Pharmaceutical price target raised to $33 from $29 at H.C. Wainwright
12/29/20 Needham
Needham names Collegium Pharma Top Pick for 2021, adds to Conviction List
COLL Collegium Pharmaceutical
$24.83 /

-0.1 (-0.40%)

Earnings
Axon reports Q2 adjusted EPS 38c, consensus 22c » 16:14
08/05/21
08/05
16:14
08/05/21
16:14
AXON

Axon

$193.11 /

+1.8 (+0.94%)

Reports Q2 revenue $219M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXON Axon
$193.11 /

+1.8 (+0.94%)

AXON Axon
$193.11 /

+1.8 (+0.94%)

06/30/21 Raymond James
Axon price target raised to $200 from $150 at Raymond James
05/19/21
Fly Intel: Top five analyst upgrades
05/19/21 Raymond James
Axon upgraded to Strong Buy from Market Perform at Raymond James
05/19/21 Raymond James
Axon upgraded to Strong Buy from Market Perform at Raymond James
AXON Axon
$193.11 /

+1.8 (+0.94%)

AXON Axon
$193.11 /

+1.8 (+0.94%)

Earnings
Plug Power reports Q2 EPS (18c), consensus (8c) » 16:14
08/05/21
08/05
16:14
08/05/21
16:14
PLUG

Plug Power

$26.01 /

+0.12 (+0.46%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PLUG Plug Power
$26.01 /

+0.12 (+0.46%)

PLUG Plug Power
$26.01 /

+0.12 (+0.46%)

07/23/21
Fly Intel: Top five analyst initiations
07/23/21 Citi
Plug Power initiated with a Buy at Citi
07/15/21
Fly Intel: Top five analyst initiations
07/15/21 Seaport Global
Plug Power initiated with a Buy at Seaport Global
PLUG Plug Power
$26.01 /

+0.12 (+0.46%)

  • 27
    Jan
  • 17
    Nov
  • 12
    Aug
PLUG Plug Power
$26.01 /

+0.12 (+0.46%)

PLUG Plug Power
$26.01 /

+0.12 (+0.46%)

PLUG Plug Power
$26.01 /

+0.12 (+0.46%)

Hot Stocks
Ocular Therapeutix terminates collaboration with Regeneron » 16:14
08/05/21
08/05
16:14
08/05/21
16:14
OCUL

Ocular Therapeutix

$10.82 /

+0.3 (+2.85%)

, REGN

Regeneron

$602.38 /

+22.195 (+3.83%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCUL Ocular Therapeutix
$10.82 /

+0.3 (+2.85%)

REGN Regeneron
$602.38 /

+22.195 (+3.83%)

OCUL Ocular Therapeutix
$10.82 /

+0.3 (+2.85%)

02/12/21 Piper Sandler
Ocular Therapeutix to update on OTX-TKI's Phase I wAMD, says Piper Sandler
12/30/20 JMP Securities
Ocular Therapeutix price target raised to $30 from $20 at JMP Securities
12/28/20
Fly Intel: Top five analyst calls
12/28/20 H.C. Wainwright
Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright
REGN Regeneron
$602.38 /

+22.195 (+3.83%)

15:43 Today Piper Sandler
Regeneron price target raised to $675 from $650 at Piper Sandler
08/02/21 H.C. Wainwright
Regeneron price target raised to $741 from $729 at H.C. Wainwright
07/29/21 H.C. Wainwright
Regeneron price target raised to $729 from $703 at H.C. Wainwright
07/23/21 RBC Capital
Regeneron price target raised to $679 from $629 at RBC Capital
OCUL Ocular Therapeutix
$10.82 /

+0.3 (+2.85%)

REGN Regeneron
$602.38 /

+22.195 (+3.83%)

  • 16
    Dec
  • 14
    Oct
REGN Regeneron
$602.38 /

+22.195 (+3.83%)

OCUL Ocular Therapeutix
$10.82 /

+0.3 (+2.85%)

REGN Regeneron
$602.38 /

+22.195 (+3.83%)

REGN Regeneron
$602.38 /

+22.195 (+3.83%)

Earnings
Ellington Financial reports Q2 core EPS 51c, consensus 45c » 16:14
08/05/21
08/05
16:14
08/05/21
16:14
EFC

Ellington Financial

$18.13 /

+0.02 (+0.11%)

"Ellington Financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EFC Ellington Financial
$18.13 /

+0.02 (+0.11%)

EFC Ellington Financial
$18.13 /

+0.02 (+0.11%)

06/07/21 UBS
Ellington Financial downgraded to Neutral from Buy at UBS
05/19/21 BTIG
Ellington Financial price target raised to $19 from $18.50 at BTIG
01/15/21 UBS
Ellington Financial initiated with a Buy at UBS
12/18/20 Keefe Bruyette
Ellington Financial upgraded to Outperform from Market Perform at Keefe Bruyette
EFC Ellington Financial
$18.13 /

+0.02 (+0.11%)

  • 07
    Jul
Hot Stocks
TripAdvisor reports June monthly unique users up 79% » 16:13
08/05/21
08/05
16:13
08/05/21
16:13
TRIP

TripAdvisor

$37.97 /

+1.905 (+5.28%)

April, May, and June 2021…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRIP TripAdvisor
$37.97 /

+1.905 (+5.28%)

TRIP TripAdvisor
$37.97 /

+1.905 (+5.28%)

06/16/21 Truist
TripAdvisor rolls out subscription product 'on schedule,' says Truist
06/14/21 Ascendiant
TripAdvisor price target raised to $54 from $50 at Ascendiant
05/10/21 Gordon Haskett
TripAdvisor unused convertible funds still 'on radar,' says Gordon Haskett
05/10/21 Credit Suisse
TripAdvisor price target raised to $37 from $31 at Credit Suisse
TRIP TripAdvisor
$37.97 /

+1.905 (+5.28%)

TRIP TripAdvisor
$37.97 /

+1.905 (+5.28%)

TRIP TripAdvisor
$37.97 /

+1.905 (+5.28%)

TRIP TripAdvisor
$37.97 /

+1.905 (+5.28%)

Earnings
Sangamo reports Q2 EPS (33c), consensus (31c) » 16:13
08/05/21
08/05
16:13
08/05/21
16:13
SGMO

Sangamo

$9.97 /

+0.49 (+5.17%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGMO Sangamo
$9.97 /

+0.49 (+5.17%)

SGMO Sangamo
$9.97 /

+0.49 (+5.17%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright
SGMO Sangamo
$9.97 /

+0.49 (+5.17%)

Earnings
IFF raises FY21 revenue view to roughly $11.4B from $11.25B  16:13
08/05/21
08/05
16:13
08/05/21
16:13
IFF

IFF

$148.04 /

+0.24 (+0.16%)

Consensus $11.26B.

ShowHide Related Items >><<
IFF IFF
$148.04 /

+0.24 (+0.16%)

IFF IFF
$148.04 /

+0.24 (+0.16%)

07/20/21 Redburn
IFF initiated with a Buy at Redburn
06/28/21 Wells Fargo
IFF price target raised to $168 from $160 at Wells Fargo
05/13/21 Jefferies
IFF price target raised to $160 from $155 at Jefferies
05/12/21 Wells Fargo
IFF price target raised to $160 from $155 at Wells Fargo
IFF IFF
$148.04 /

+0.24 (+0.16%)

IFF IFF
$148.04 /

+0.24 (+0.16%)

IFF IFF
$148.04 /

+0.24 (+0.16%)

Earnings
TripAdvisor reports Q2 EPS (7c), consensus (11c) » 16:13
08/05/21
08/05
16:13
08/05/21
16:13
TRIP

TripAdvisor

$37.88 /

+1.815 (+5.03%)

Reports Q2 revenue $235M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRIP TripAdvisor
$37.88 /

+1.815 (+5.03%)

TRIP TripAdvisor
$37.88 /

+1.815 (+5.03%)

06/16/21 Truist
TripAdvisor rolls out subscription product 'on schedule,' says Truist
06/14/21 Ascendiant
TripAdvisor price target raised to $54 from $50 at Ascendiant
05/10/21 Gordon Haskett
TripAdvisor unused convertible funds still 'on radar,' says Gordon Haskett
05/10/21 Credit Suisse
TripAdvisor price target raised to $37 from $31 at Credit Suisse
TRIP TripAdvisor
$37.88 /

+1.815 (+5.03%)

TRIP TripAdvisor
$37.88 /

+1.815 (+5.03%)

TRIP TripAdvisor
$37.88 /

+1.815 (+5.03%)

TRIP TripAdvisor
$37.88 /

+1.815 (+5.03%)

Earnings
iCAD reports Q2 EPS (11c), consensus (7c) » 16:12
08/05/21
08/05
16:12
08/05/21
16:12
ICAD

iCAD

$15.30 /

+1.1 (+7.75%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ICAD iCAD
$15.30 /

+1.1 (+7.75%)

ICAD iCAD
$15.30 /

+1.1 (+7.75%)

04/22/21 Guggenheim
iCAD initiated with a Buy at Guggenheim
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
03/23/21 BTIG
iCAD initiated with a Buy at BTIG
02/26/21 B. Riley Securities
iCAD price target raised to $23 from $18 at B. Riley Securities
ICAD iCAD
$15.30 /

+1.1 (+7.75%)

  • 03
    Mar
ICAD iCAD
$15.30 /

+1.1 (+7.75%)

Earnings
Funko reports Q2 EPS 36c, consensus 18c » 16:12
08/05/21
08/05
16:12
08/05/21
16:12
FNKO

Funko

$20.11 /

+0.64 (+3.29%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FNKO Funko
$20.11 /

+0.64 (+3.29%)

FNKO Funko
$20.11 /

+0.64 (+3.29%)

07/23/21 BMO Capital
BMO 'increasingly more concerned' about guidance from toy companies
05/13/21 BofA
Funko upgraded to Buy from Underperform at BofA
05/07/21 Truist
Funko price target raised to $25 from $18 at Truist
05/07/21 DA Davidson
Funko upgraded to Buy from Neutral at DA Davidson
FNKO Funko
$20.11 /

+0.64 (+3.29%)

FNKO Funko
$20.11 /

+0.64 (+3.29%)

FNKO Funko
$20.11 /

+0.64 (+3.29%)

FNKO Funko
$20.11 /

+0.64 (+3.29%)

Earnings
IFF reports Q2 adjusted EPS $1.50, consensus $1.48 » 16:12
08/05/21
08/05
16:12
08/05/21
16:12
IFF

IFF

$148.00 /

+0.2 (+0.14%)

Reports Q2 revenue $3.1B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IFF IFF
$148.00 /

+0.2 (+0.14%)

IFF IFF
$148.00 /

+0.2 (+0.14%)

07/20/21 Redburn
IFF initiated with a Buy at Redburn
06/28/21 Wells Fargo
IFF price target raised to $168 from $160 at Wells Fargo
05/13/21 Jefferies
IFF price target raised to $160 from $155 at Jefferies
05/12/21 Wells Fargo
IFF price target raised to $160 from $155 at Wells Fargo
IFF IFF
$148.00 /

+0.2 (+0.14%)

IFF IFF
$148.00 /

+0.2 (+0.14%)

IFF IFF
$148.00 /

+0.2 (+0.14%)

Earnings
Redfin sees Q3 revenue $530M-$541M, consensus $487.98M » 16:12
08/05/21
08/05
16:12
08/05/21
16:12
RDFN

Redfin

$60.65 /

+1.43 (+2.41%)

Sees Q3 net loss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDFN Redfin
$60.65 /

+1.43 (+2.41%)

RDFN Redfin
$60.65 /

+1.43 (+2.41%)

07/21/21 Berenberg
Redfin initiated with a Hold at Berenberg
06/03/21
Fly Intel: Top five analyst upgrades
06/03/21 Stephens
Redfin upgraded to Overweight from Equal Weight at Stephens
05/26/21 RBC Capital
Redfin assumed with an Outperform at RBC Capital
RDFN Redfin
$60.65 /

+1.43 (+2.41%)

RDFN Redfin
$60.65 /

+1.43 (+2.41%)

RDFN Redfin
$60.65 /

+1.43 (+2.41%)

RDFN Redfin
$60.65 /

+1.43 (+2.41%)

Hot Stocks
GoPro closes Q2 with 1,160,000 GoPro subscribers, up 23% sequentially » 16:12
08/05/21
08/05
16:12
08/05/21
16:12
GPRO

GoPro

$10.03 /

+0.15 (+1.52%)

Closed Q2 with 1,160,000…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPRO GoPro
$10.03 /

+0.15 (+1.52%)

GPRO GoPro
$10.03 /

+0.15 (+1.52%)

02/08/21 Citi
GoPro price target raised to $6 from $3 at Citi
GPRO GoPro
$10.03 /

+0.15 (+1.52%)

GPRO GoPro
$10.03 /

+0.15 (+1.52%)

GPRO GoPro
$10.03 /

+0.15 (+1.52%)

Hot Stocks
Cornerstone OnDemand bought by Clearlake for $57.50 per share or $5.2B » 16:12
08/05/21
08/05
16:12
08/05/21
16:12
CSOD

Cornerstone OnDemand

$49.95 /

+0.47 (+0.95%)

Cornerstone OnDemand…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSOD Cornerstone OnDemand
$49.95 /

+0.47 (+0.95%)

CSOD Cornerstone OnDemand
$49.95 /

+0.47 (+0.95%)

06/30/21 Berenberg
Cornerstone OnDemand initiated with a Buy at Berenberg
05/07/21 BMO Capital
Cornerstone OnDemand price target lowered to $50 from $63 at BMO Capital
04/27/21 JMP Securities
Workday price target raised to $310 from $296 at JMP Securities
03/26/21 DA Davidson
DA Davidson sees 'material' COVID tailwinds for Cornerstone OnDemand
CSOD Cornerstone OnDemand
$49.95 /

+0.47 (+0.95%)

CSOD Cornerstone OnDemand
$49.95 /

+0.47 (+0.95%)

Earnings
Illumina sees FY21 adjusted EPS $6.30-$6.50, consensus $6.02 » 16:12
08/05/21
08/05
16:12
08/05/21
16:12
ILMN

Illumina

$514.50 /

+9.9 (+1.96%)

For fiscal 2021, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$514.50 /

+9.9 (+1.96%)

ILMN Illumina
$514.50 /

+9.9 (+1.96%)

07/13/21 Barclays
Illumina price target raised to $355 from $300 at Barclays
06/01/21 Evercore ISI
Evercore ISI upgrades Illumina to In Line on base business turnaround
06/01/21 Evercore ISI
Illumina upgraded to In Line from Underperform at Evercore ISI
04/28/21 Wells Fargo
Illumina price target raised to $340 from $330 at Wells Fargo
ILMN Illumina
$514.50 /

+9.9 (+1.96%)

ILMN Illumina
$514.50 /

+9.9 (+1.96%)

ILMN Illumina
$514.50 /

+9.9 (+1.96%)

ILMN Illumina
$514.50 /

+9.9 (+1.96%)

Earnings
Monster Beverage reports Q2 EPS 75c, consensus 68c » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
MNST

Monster Beverage

$92.01 /

-0.02 (-0.02%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNST Monster Beverage
$92.01 /

-0.02 (-0.02%)

07/30/21 Deutsche Bank
Monster Beverage price target raised to $108 from $105 at Deutsche Bank
07/23/21
Fly Intel: Top five analyst upgrades
07/23/21 Citi
Monster Beverage upgraded to Buy from Neutral at Citi
06/02/21 Morgan Stanley
Survey increases confidence in Monster Beverage outlook, says Morgan Stanley
MNST Monster Beverage
$92.01 /

-0.02 (-0.02%)

MNST Monster Beverage
$92.01 /

-0.02 (-0.02%)

MNST Monster Beverage
$92.01 /

-0.02 (-0.02%)

MNST Monster Beverage
$92.01 /

-0.02 (-0.02%)

Earnings
GoPro reports Q2 adjusted EPS 12c, consensus 4c » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
GPRO

GoPro

$10.03 /

+0.15 (+1.52%)

Reports Q2 revenue $250M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GPRO GoPro
$10.03 /

+0.15 (+1.52%)

GPRO GoPro
$10.03 /

+0.15 (+1.52%)

02/08/21 Citi
GoPro price target raised to $6 from $3 at Citi
GPRO GoPro
$10.03 /

+0.15 (+1.52%)

GPRO GoPro
$10.03 /

+0.15 (+1.52%)

GPRO GoPro
$10.03 /

+0.15 (+1.52%)

Earnings
iRhythm Sees FY21 revenue $320M-$325M, consensus $302.33M » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
IRTC

iRhythm

$48.28 /

-1.43 (-2.88%)

For FY21, the company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRTC iRhythm
$48.28 /

-1.43 (-2.88%)

IRTC iRhythm
$48.28 /

-1.43 (-2.88%)

06/02/21 Citi
iRhythm downgraded to Neutral from Buy at Citi
04/14/21 Morgan Stanley
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley
04/13/21 Truist
iRhythm price target lowered to $115 from $220 at Truist
04/13/21 BTIG
iRhythm downgraded to Neutral from Buy at BTIG
IRTC iRhythm
$48.28 /

-1.43 (-2.88%)

  • 10
    Jun
  • 19
    Aug
IRTC iRhythm
$48.28 /

-1.43 (-2.88%)

IRTC iRhythm
$48.28 /

-1.43 (-2.88%)

Hot Stocks
Zynga to acquire StarLark for $525M in cash, stock » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
ZNGA

Zynga

$9.78 /

-0.105 (-1.06%)

Zynga announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

06/30/21 Morgan Stanley
Morgan Stanley double downgrades overvalued AppLovin to Underweight
05/06/21
Fly Intel: Top five analyst upgrades
05/06/21 BofA
Zynga upgraded to Buy from Neutral at BofA
05/06/21 BofA
Zynga upgraded to Buy from Neutral at BofA
ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

  • 07
    Aug
ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

ZNGA Zynga
$9.78 /

-0.105 (-1.06%)

Earnings
Redfin reports Q2 EPS (29c), consensus (33c) » 16:11
08/05/21
08/05
16:11
08/05/21
16:11
RDFN

Redfin

$60.75 /

+1.53 (+2.58%)

Reports Q2 revenue $471M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDFN Redfin
$60.75 /

+1.53 (+2.58%)

RDFN Redfin
$60.75 /

+1.53 (+2.58%)

07/21/21 Berenberg
Redfin initiated with a Hold at Berenberg
06/03/21
Fly Intel: Top five analyst upgrades
06/03/21 Stephens
Redfin upgraded to Overweight from Equal Weight at Stephens
05/26/21 RBC Capital
Redfin assumed with an Outperform at RBC Capital
RDFN Redfin
$60.75 /

+1.53 (+2.58%)

RDFN Redfin
$60.75 /

+1.53 (+2.58%)

RDFN Redfin
$60.75 /

+1.53 (+2.58%)

RDFN Redfin
$60.75 /

+1.53 (+2.58%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.